Keros Therapeutics, Inc. · NASDAQ:KROS
Newton Charles W. sold 551 Keros Therapeutics, Inc. shares (Form 4)
Traded Aug 18, 2026 · Filed Aug 20, 2026
On Aug 18, 2026, Newton Charles W. (Director) sold 551 Keros Therapeutics, Inc. shares at US$10.30 for US$5,675 under a trading plan, leaving 12,114 shares. Filed Aug 20, 2026 (Form 4).
- Sold
- 551 shares
- Price
- US$10.30
- Value
- US$5,675
- Holding after
- 12,114 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 18, 2026 | Common Stock | Sale | 551 | US$10.30 | 12,114 | Direct |
Source
Related
- Keros Therapeutics, Inc.
- Newton Charles W.
- Keros Therapeutics, Inc. shareholders
- Form 4 · Newton Charles W. · Jun 15, 2026
- Form 4 · Tanini Annita · Aug 20, 2026
- Form 4 · Lerner Lorena Raquel · Aug 20, 2026
- Form 4 · Cho Esther · Aug 20, 2026
- Form 4 · Bienaime Jean Jacques · Aug 19, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 29, 2026